Join our next Deal Talk webinar featuring the iconic David Rubenstein
Join our next Deal Talk webinar featuring the iconic David Rubenstein

We’re interviewing the legendary David Rubenstein and you’re invited.

This exclusive Deal Talk episode will feature the iconic private equity leader who is the Co-Founder and Co-Chairman of Carlyle. 

This unique session is a great opportunity to gain insights from one of the world’s most influential investors. Immerse yourself in his wealth of experience and discover the strategies behind his remarkable success.

So, join Moonfare’s Founder and Co-CEO, Dr Steffen Pauls, as he hosts this exciting Deal Talk episode.

Meet David Rubenstein

  • Mr Rubenstein is the Co-Founder and Co-Chairman of Carlyle, one of the world’s largest and most successful private investment firms. Established in 1987, Carlyle now manages $382 billion from 28 offices around the world.
  • Among his many philanthropic endeavours, Mr Rubenstein is Chairman of the Boards of the John F Kennedy Center for the Performing Arts and the University of Chicago. He also sits on the Boards of Memorial Sloan-Kettering Cancer Center, Johns Hopkins Medicine, the Lincoln Center for the Performing Arts, the American Academy of Arts and Sciences and the World Economic Forum.
  • He has served as Chairman of the Boards of Duke University and the Smithsonian Institution, Co-Chairman of the Board of the Brookings Institution and as a Fellow of the Harvard Corporation.

We hope you will join us for this special Deal Talk webinar.

Avis important: Ce contenu est fourni à des fins informatives uniquement. Moonfare ne fournit pas de conseils en investissement. Vous ne devez pas interpréter les informations ou autres documents fournis comme des conseils juridiques, fiscaux, d'investissement, financiers ou autres. Si vous avez des doutes, vous devez demander des conseils financiers auprès d'un conseiller autorisé. Les performances passées ne sont pas un guide fiable pour les rendements futurs. N'investissez pas si vous n'êtes pas prêt à perdre tout l'argent que vous investissez. Il s'agit d'un investissement à haut risque et vous avez peu de chances d'être protégé en cas de problème. Sous réserve d'éligibilité. Veuillez consulter https://www.moonfare.com/disclaimers.
Join Moonfare Now.
Benefit from what institutional investors already know: the greatest shareholder value comes from private markets, and funds like those offered on Moonfare have generated an average IRR of 19% — outperforming the S&P 500 by 13%.*
partnerships-image
Join The Satellite.
Weekly updates on Investment and Finance.
Subscribe Now
arrow icon
arrow icon